Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
JAZZ | Jazz Pharmaceuticals plc | Tobias Jeffrey K | EVP, R&D & CMO | Mar 05, 2015 | Option Exercise | $174.76 | 1,630 | 284,859 | 38,484 | Mar 09, 2015, 09:03 PM | |
JAZZ | Jazz Pharmaceuticals plc | Tobias Jeffrey K | EVP, R&D & CMO | Feb 27, 2015 | Option Exercise | $170.09 | 704 | 119,743 | 40,114 | Mar 02, 2015, 06:58 PM | |
JAZZ | Jazz Pharmaceuticals plc | Tobias Jeffrey K | EVP, R&D & CMO | Feb 10, 2015 | Sale | $106.83 | 10,000 | 1,068,268 | 40,063 | Feb 12, 2015, 07:38 PM | |
JAZZ | Jazz Pharmaceuticals plc | Tobias Jeffrey K | EVP, Research & Dev and CMO | Nov 24, 2014 | Sale | $170.12 | 4,598 | 782,230 | 34,940 | Nov 25, 2014, 06:51 PM | |
JAZZ | Jazz Pharmaceuticals plc | Tobias Jeffrey K | EVP, Research & Dev and CMO | Nov 14, 2014 | Sale | $173.32 | 1,000 | 173,320 | 39,538 | Nov 18, 2014, 05:40 PM | |
JAZZ | Jazz Pharmaceuticals plc | Tobias Jeffrey K | EVP, Research & Dev and CMO | Oct 10, 2014 | Sale | $154.04 | 1,000 | 154,040 | 40,538 | Oct 14, 2014, 06:35 PM | |
JAZZ | Jazz Pharmaceuticals plc | Tobias Jeffrey K | EVP, Research & Dev and CMO | Sep 12, 2014 | Sale | $171.22 | 1,000 | 171,220 | 41,538 | Sep 15, 2014, 07:10 PM | |
JAZZ | Jazz Pharmaceuticals plc | Tobias Jeffrey K | EVP, Research & Dev and CMO | Aug 11, 2014 | Option Exercise | $106.67 | 14,431 | 1,539,286 | 47,471 | Aug 13, 2014, 06:51 PM | |
JAZZ | Jazz Pharmaceuticals plc | Tobias Jeffrey K | EVP, Research & Dev and CMO | Jun 09, 2014 | Option Exercise | $97.43 | 6,000 | 584,610 | 50,103 | Jun 11, 2014, 06:30 PM | |
JAZZ | Jazz Pharmaceuticals plc | Tobias Jeffrey K | EVP, Research & Dev and CMO | May 16, 2014 | Sale | $128.01 | 1,000 | 128,010 | 47,103 | May 20, 2014, 05:10 PM | |
JAZZ | Jazz Pharmaceuticals plc | Tobias Jeffrey K | EVP, Research & Dev and CMO | Apr 14, 2014 | Sale | $91.21 | 6,000 | 547,266 | 51,103 | Apr 16, 2014, 07:41 PM | |
JAZZ | Jazz Pharmaceuticals plc | Tobias Jeffrey K | EVP, Research & Dev and CMO | Mar 10, 2014 | Option Exercise | $103.43 | 6,000 | 620,604 | 51,103 | Mar 12, 2014, 06:06 PM | |
JAZZ | Jazz Pharmaceuticals plc | Tobias Jeffrey K | EVP, Research & Dev and CMO | Mar 05, 2014 | Option Exercise | $157.60 | 1,174 | 185,022 | 48,103 | Mar 06, 2014, 07:28 PM | |
JAZZ | Jazz Pharmaceuticals plc | Tobias Jeffrey K | EVP, Research & Dev and CMO | Feb 27, 2014 | Sale | $165.46 | 3,000 | 496,380 | 41,777 | Mar 03, 2014, 08:05 PM | |
JAZZ | Jazz Pharmaceuticals plc | Tobias Jeffrey K | EVP, Research & Dev and CMO | Feb 10, 2014 | Sale | $99.83 | 5,120 | 511,130 | 47,337 | Feb 12, 2014, 07:18 PM | |
JAZZ | Jazz Pharmaceuticals plc | Tobias Jeffrey K | EVP, Research & Dev and CMO | Dec 09, 2013 | Sale | $82.32 | 2,650 | 218,135 | 46,102 | Dec 11, 2013, 07:01 PM | |
JAZZ | Jazz Pharmaceuticals plc | Tobias Jeffrey K | EVP, Research & Dev and CMO | Nov 11, 2013 | Option Exercise | $72.67 | 4,746 | 344,868 | 46,778 | Nov 13, 2013, 06:57 PM | |
JAZZ | Jazz Pharmaceuticals plc | Tobias Jeffrey K | EVP, Research & Dev and CMO | Oct 14, 2013 | Sale | $64.73 | 10,000 | 647,268 | 49,405 | Oct 16, 2013, 06:54 PM | |
JAZZ | Jazz Pharmaceuticals plc | Tobias Jeffrey K | EVP, Research & Dev and CMO | Sep 09, 2013 | Sale | $66.97 | 10,000 | 669,700 | 49,405 | Sep 10, 2013, 06:03 PM | |
JAZZ | Jazz Pharmaceuticals plc | Tobias Jeffrey K | EVP, Research & Dev and CMO | Aug 09, 2013 | Option Exercise | $80.88 | 3,288 | 265,933 | 44,405 | Aug 13, 2013, 09:03 PM | |
JAZZ | Jazz Pharmaceuticals plc | Tobias Jeffrey K | EVP, Research & Dev and CMO | Aug 12, 2013 | Sale | $63.80 | 15,000 | 957,000 | 51,905 | Aug 13, 2013, 09:03 PM | |
NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev & CMO | May 17, 2011 | Sale | $2.73 | 1,333 | 3,639 | 6,114 | May 19, 2011, 04:19 PM | |
NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev & CMO | May 18, 2011 | Sale | $2.82 | 1,115 | 3,144 | 4,999 | May 19, 2011, 04:19 PM | |
NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev & CMO | May 12, 2011 | Sale | $2.91 | 600 | 1,746 | 8,180 | May 16, 2011, 09:05 PM | |
NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev & CMO | May 13, 2011 | Sale | $2.81 | 733 | 2,060 | 7,447 | May 16, 2011, 09:05 PM | |
NGSX | NeurogesX Inc | Tobias Jeffrey K | EVP Research & Dev & CMO | May 16, 2011 | Sale | $2.84 | 1,333 | 3,786 | 7,447 | May 16, 2011, 09:05 PM |